))
ResMed wins patent spat with NYU, Haemonetics closes $255M OpSens buy
Manage episode 389187953 series 3481361
Contenuto fornito da Fast Five by MassDevice. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Fast Five by MassDevice o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 13, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Cognito Therapeutics reported non-invasive neuromod data for treating Alzheimers this week. Fast Five hosts Danielle Kirsh and Sean Whooley talk about how the company's technology works and some of the data points that stuck out in the report. Shifamed's Laza Medical closed a $36M Series A funding round to support cardiac imaging technology. Hear what the technology is and what the company hopes to achieve with the imaging technology. Vivasure has treated the first patients with its percutaneous vessel closure device. Learn more about how the device works and what makes it unique in today's episode. Haemonetics has closed its previously announced acquisition of OpSens. Whooley explains what OpSens brings to Haemonetics and some of the financial details of the deal. ResMed has won a patent spat with NYU. The Fast Five hosts discuss the details of the patent spat and the device behind the legal battle.
…
continue reading
161 episodi
Condividi
